The Dry Eye Disease market report covers emerging drugs, current treatment practices, Dry Eye Disease market share of the individual therapies, current and forecasted Dry Eye Disease Market Size from 2017 to 2030 segmented by seven major markets.
The report also provides detailed current Dry Eye Disease treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.
Dry Eye Disease Market Key Facts
According to Dana R. et al., in the United States, overall DED prevalence was 5.28%, with female prevalence of about 7.78%, and 2.96% among male beneficiaries and increased with age from 0.20% for ages 2‐17 years, to 11.66% for individuals aged 50+ years. (2019).
As per Delveinsight’s estimates, the total prevalent population of Dry Eye Disease in EU5 was 11,939,169 in 2017.
Among the European five countries, Germany had the highest prevalent population of Dry Eye Disease, followed by the United Kingdom, France and Italy. On the other hand, Spain had the lowest prevalent population of Dry Eye Disease.
Visit For Sample Pages:
Key Benefits of Dry Eye Disease Market Report
Dry Eye Disease market report provides an in-depth analysis of Dry Eye Disease Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major market i.e. EU5 (Germany, Italy, Spain, France and the UK), Japan, and the United States.
The Dry Eye Disease market report will help in developing business strategies by understanding the Dry Eye Disease Market trends & developments, key players and future market competition that will shape and drive the Dry Eye Disease market in the upcoming years.
The Dry Eye Disease market report covers Dry Eye Disease current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.
The report provides a detailed assessment of the Dry Eye Disease market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population, comparative analysis of pipeline products with detailed clinical profiles, and other factors.
The Dry Eye Disease market outlook section of the report helps to build the detailed comprehension of the historic, current and forecasted Dry Eye Disease market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology.
The report gives a thorough detail of Dry Eye Disease market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.
The Dry Eye Disease epidemiology section covers insights about historical and current Dry Eye Disease patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.
It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Dry Eye Disease Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Dry Eye Disease market or expected to get launched in the market during the study period. The analysis covers Dry Eye Disease market uptake by drugs; patient uptake by therapies; and sales of each drug.
Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Some of the emerging therapies in Dry Eye Disease market include:
KPI‐121 And others
Key companies in Dry Eye Disease market include:
Oyster Point Pharma
Mimetogen Pharmaceuticals And others
Table of Content
1. Key Insights
2. Executive Summary
3. Dry Eye Disease Competitive Intelligence Analysis
4. Dry Eye Disease Market Overview at a Glance
5. Dry Eye Disease Disease Background and Overview
6. Dry Eye Disease Patient Journey
7. Dry Eye Disease Epidemiology and Patient Population
8. Dry Eye Disease Treatment Algorithm, Current Treatment, and Medical Practices
9. Dry Eye Disease Unmet Needs
10. Key Endpoints of Dry Eye Disease Treatment
11. Dry Eye Disease Marketed Products
12. Dry Eye Disease Emerging Therapies
13. Dry Eye Disease Seven Major Market Analysis
14. Attribute Analysis
15. Dry Eye Disease Market Outlook (7 major markets)
16. Dry Eye Disease Access and Reimbursement Overview
17. KOL Views on the Dry Eye Disease Market.
18. Dry Eye Disease Market Drivers
19. Dry Eye Disease Market Barriers
21. DelveInsight Capabilities
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.
Company Name: DelveInsight Business Research LLP
Contact Person: Anuj Rawat
Email: Send Email
Address:304 S. Jones Blvd #2432
State: New York
Country: United States